With a robust scientific-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, which include Retrocyte Display screen™ and SECANT®, and innovative mobile therapy techniques, positioning by itself like a crucial contributor inside the biotechnology and immunotherapy arena.Sustaining independence and editorial independence is i